Improving the design of maintenance studies for bipolar disorder

Current Medical Research and Opinion

Volumn 26, Issue 8, 2010, Pages 1835-1842

  Gitlin, Michael J ^a   Abulseoud, Osama ^b   Frye, Mark A ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c MAYO CLINIC   (United States)

Author keywords

Bipolar disorder; Bipolar maintenance therapy; Pharmacotherapy; Relapse; Stabilization

Indexed keywords

ARIPIPRAZOLE; LAMOTRIGINE; LITHIUM; OLANZAPINE; VALPROIC ACID;

ALGORITHM; BIPOLAR DISORDER; CLINICAL ASSESSMENT; CLINICAL PRACTICE; CLINICAL STUDY; COMORBIDITY; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRUG BLOOD LEVEL; DRUG EFFICACY; HOSPITALIZATION; HUMAN; HYPOMANIA; INFORMATION RETRIEVAL; MAINTENANCE THERAPY; MANIA; MEDLINE; METHODOLOGY; OUTCOME ASSESSMENT; RELAPSE; SCREENING; SHORT SURVEY; THERAPY EFFECT; TREATMENT DURATION;

ANTIMANIC AGENTS; BIPOLAR DISORDER; HUMANS; LITHIUM CARBONATE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECURRENCE;

EID: 77954738014     PISSN: 03007995     EISSN: 14734877     Source Type: Journal    
DOI: 10.1185/03007995.2010.489830     Document Type: Short Survey

References (29)

1. Hirschfeld RMA, Bowden CL, Gitlin MJ, et al. American Psychiatric Association practice guideline for the treatment of patients with bipolar disorder (Revision). American J Psychiatry 2002;159(Suppl. 4):1-50
2. Goodwin FK, Jamison KR. Manic-Depressive Illness: Bipolar Disorders and Recurrent Depression, 2nd Edn. NY: Oxford University Press, 2007
3. Perlis RH, Ostacher MJ, Patel JK, et al. Predictors of recurrence in bipolar disorder: primary outcomes from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Am J Psychiatry 2006;163:217-24
4. Gitlin MJ, Swendsen J, Heller TL, Hammen C. Relapse and impairment in bipolar disorder. Am J Psychiatry 1995;152:1635-40
5. Winokur G, Coryell W, Akiskal HS, et al. Manic-depressive (bipolar) disorder: the course in light of a prospective ten-year follow-up of 131 patients. Acta Psychiatr Scand 1994; 89:102-10
6. Levine J, Chengappa KNR, Brar JS, et al. Psychotropic drug prescription patterns among patients with bipolar I disorder. Bipolar Disord 2000; 2:120-30
7. Nolen WA, Luckenbaugh DA, Altshuler LL, et al. Correlates of 1-year prospective outcome in bipolar disorder: results from the Stanley foundation bipolar network. Am J Psychiatry 2004;161:1447-54
8. Judd LL, Akiskal HS, Schettler PJ, et al. A prospective investigation of the natural history of the long-term weekly symptomatic status of bipolar II disorder. Arch Gen Psychiatry 2003;60:261-9
9. Judd LL, Akiskal HS, Schettler PJ, et al. The long-term natural history of the weekly symptomatic status of bipolar I disorder. Arch Gen Psychiatry 2002; 59:530-7
10. Prien RF, Caffey Jr EM, Klett CJ. Prophylactic efficacy of lithium carbonate in manic-depressive illness. Report of the Veterans Administration and National Institute of Mental Health collaborative study group. Arch Gen Psychiatry 1973;28:337-41
11. Bowden CL, Calabrese JR, McElroy SL, et al. A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Divalproex Maintenance Study Group. Arch Gen Psychiatry 2000;57:481-9
12. Tohen M, Calabrese JR, Sachs GS, et al. Randomized, placebo-controlled trial of olanzapine as maintenance therapy in patients with bipolar I disorder responding to acute treatment with olanzapine. Am J Psychiatry 2006;163: 247-56
13. Bowden CL, Calabrese JR, Sachs G, et al. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypo-manic patients with bipolar I disorder. Arch Gen Psychiatry 2003;60:392-400 (Pubitemid 36403000)
14. Calabrese JR, Bowden CL, Sachs G, et al. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder. J Clin Psychiatry 2003;64:1013-24
15. Keck Jr PE, Calabrese JR, McQuade RD, et al. A randomized, double-blind, placebo-controlled 26-week trial of aripiprazole in recently manic patients with bipolar I disorder. J Clin Psychiatry 2006;67:626-37
16. Keck Jr PE, Calabrese JR, McIntyre RS, et al. Aripiprazole monotherapy for maintenance therapy in bipolar I disorder: a 100-week, double-blind study versus placebo. J Clin Psychiatry 2007;68:1480-91
17. Tohen M, Chengappa KN, Suppes T, et al. Relapse prevention in bipolar I disorder: 18-month comparison of olanzapine plus mood stabiliser v. mood stabiliser alone. Br J Psychiatry 2004;184:337-45
18. Vieta E, Suppes T, Eggens I, et al. Efficacy and safety of quetiapine in combination with lithium/divalproex as maintenance treatment for bipolar I disorder (international trial 126). J Affect Disord 2008;109:251-63
19. Suppes T, Vieta E, Liu S, et al. Maintenance treatment for patients with bipolar I disorder: results from a North American study of quetiapine in combination with lithium or divalproex (Trial 127). Am J Psychiatry 2009:166:476-83
20. Bowden CL, Vieta E, Ice KS, et al. Ziprasidone plus a mood stabilizer in subjects with bipolar I disorder: a 6-month, randomized, placebo-controlled, double-blind trial. J Clin Psychiatry 2010:71:130-7
21. Mcfadden W, Alphs L, Haskins TJ, et al. A randomized, double-blind, placebo-controlled study of maintenance treatment with adjunctive risperidone long-acting therapy in patients with bipolar I disorder who relapse frequently. Bipolar Disorders 2009;11:827-39
22. Data on File, File Number ABIL 046. Bristol-Myers Squibb and Otsuka America Pharmaceutical, Inc
23. Faedda GL, Tondo L, Baldessarini RJ, et al. Outcome after rapid vs gradual discontinuation of lithium treatment in bipolar disorders. Arch Gen Psychiatry 1993;50:448-55
24. Frye MA, Ketter TA, Leverich GS, et al. The increasing use of polypharma-cotherapy for refractory mood disorders: 22 years of study. J Clin Psychiatry 2000;61:9-15
25. Goldberg JF, Brooks 3rd JO, Kurita K, et al. Depressive illness burden associated with complex polypharmacy in patients with bipolar disorder: findings from the STEP-BD. J Clin Psychiatr 2009;70:155-62
26. Tohen M, Hennen J, Zarate CM, et al. Two-year syndromal and functional recovery in 219 cases of first-episode major affective disorder with psychotic features. Am J Psychiatry 2000;157:220-8
27. Geddes JR, Rendell JM, Goodwin GM, et al. BALANCE: a large simple trial of maintenance for bipolar disorder. World Psychiatry 2002;1:48-51
28. The BALANCE investigators and collaborators, Geddes JR, et al. Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open-label trial. Lancet. 2010; 375. 385-95
29. Geddes GR. BALANCE: PL Initial Results and Methodological Aspects of Trials of Maintenance Treatment. Poster presented at the 8th International Conference on Bipolar Disorder, Pittsburgh, PA, June 25-27, 2009